Ioannis Vizirianakis
Ioannis Vizirianakis
Associate Professor of Molecular Pharmacology and Pharmacogenomics
Verified email at pharm.auth.gr - Homepage
Title
Cited by
Cited by
Year
Erythropoiesis: model systems, molecular regulators, and developmental programs
AS Tsiftsoglou, IS Vizirianakis, J Strouboulis
IUBMB life 61 (8), 800-830, 2009
2322009
Mechanisms involved in the induced differentiation of leukemia cells
AS Tsiftsoglou, IS Pappas, IS Vizirianakis
Pharmacology & therapeutics 100 (3), 257-290, 2003
2052003
Reversal of P-glycoprotein-mediated multidrug resistance by diallyl sulfide in K562 leukemic cells and in mouse liver
A Arora, K Seth, Y Shukla
Carcinogenesis 25 (6), 941-949, 2004
1312004
Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes
IS Vizirianakis
Nanomedicine: Nanotechnology, Biology and Medicine 7 (1), 11-17, 2011
952011
Controlled release of 5-fluorouracil from microporous zeolites
M Spanakis, N Bouropoulos, D Theodoropoulos, L Sygellou, S Ewart, ...
Nanomedicine: Nanotechnology, Biology and Medicine 10 (1), 197-205, 2014
812014
Lipid-like self-assembling peptide nanovesicles for drug delivery
DG Fatouros, DA Lamprou, AJ Urquhart, SN Yannopoulos, IS Vizirianakis, ...
ACS applied materials & interfaces 6 (11), 8184-8189, 2014
802014
Biocompatible Zr-based nanoscale MOFs coated with modified poly (ε-caprolactone) as anticancer drug carriers
M Filippousi, S Turner, K Leus, PI Siafaka, ED Tseligka, M Vandichel, ...
International journal of pharmaceutics 509 (1-2), 208-218, 2016
722016
Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine
IS Vizirianakis
European Journal of Pharmaceutical Sciences 15 (3), 243-250, 2002
632002
Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation
E Sayed, C Karavasili, K Ruparelia, R Haj-Ahmad, G Charalambopoulou, ...
Journal of Controlled Release 278, 142-155, 2018
462018
Microfluidic transport in microdevices for rare cell capture
JP Smith, AC Barbati, SM Santana, JP Gleghorn, BJ Kirby
Electrophoresis 33 (21), 3133-3142, 2012
462012
Modified chitosan coated mesoporous strontium hydroxyapatite nanorods as drug carriers
M Filippousi, PI Siafaka, EP Amanatiadou, SG Nanaki, M Nerantzaki, ...
Journal of Materials Chemistry B 3 (29), 5991-6000, 2015
412015
Synthesis, molecular structure determination, and antitumor activity of platinum (II) and palladium (II) complexes of 2-substituted benzimidazole.
S Mylonas, A Valavanidis, K Dimitropoulos, M Polissiou, AS Tsiftsoglou, ...
Journal of inorganic biochemistry 34 (4), 265-275, 1988
401988
Development of a nanoporous and multilayer drug-delivery platform for medical implants
V Karagkiozaki, E Vavoulidis, PG Karagiannidis, M Gioti, DG Fatouros, ...
International journal of nanomedicine 7, 5327, 2012
392012
Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells
IS Vizirianakis, YQ Chen, SS Kantak, AS Tsiftsoglou, RH Kramer
International journal of oncology 21 (1), 135-144, 2002
382002
Synergistic antitumor potency of a self-assembling peptide hydrogel for the local co-delivery of doxorubicin and curcumin in the treatment of head and neck cancer
C Karavasili, DA Andreadis, OL Katsamenis, E Panteris, P Anastasiadou, ...
Molecular pharmaceutics 16 (6), 2326-2341, 2019
352019
Development of new drug delivery system based on ordered mesoporous carbons: characterisation and cytocompatibility studies
C Karavasili, EP Amanatiadou, L Sygellou, DK Giasafaki, TA Steriotis, ...
Journal of Materials Chemistry B 1 (25), 3167-3174, 2013
352013
Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives
IS Vizirianakis, M Chatzopoulou, ID Bonovolias, I Nicolaou, ...
Journal of medicinal chemistry 53 (19), 6779-6810, 2010
342010
Desmoglein-3/γ-catenin and E-cadherin/-catenin differential expression in oral leukoplakia and squamous cell carcinoma
M Kyrodimou, D Andreadis, A Drougou, EP Amanatiadou, L Angelis, ...
Clinical oral investigations 18 (1), 199-210, 2014
312014
Challenges in current drug delivery from the potential application of pharmacogenomics and personalized medicine in clinical practice
IS Vizirianakis
Current drug delivery 1 (1), 73-80, 2004
302004
Expression of ribosomal protein S5 cloned gene during differentiation and apoptosis in murine erythroleukemia (MEL) cells.
IS Vizirianakis, IS Pappas, D Gougoumas, AS Tsiftsoglou
Oncology research 11 (9), 409-419, 1999
301999
The system can't perform the operation now. Try again later.
Articles 1–20